These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19723913)

  • 1. The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitors.
    O'Mara TA; Clements JA; Spurdle AB
    Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2352-65. PubMed ID: 19723913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
    Decock J; Paridaens R; Ye S
    Clin Genet; 2008 Mar; 73(3):197-211. PubMed ID: 18177467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase proteomics: substrates, targets, and therapy.
    Morrison CJ; Butler GS; Rodríguez D; Overall CM
    Curr Opin Cell Biol; 2009 Oct; 21(5):645-53. PubMed ID: 19616423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of matrix metalloproteinases in breast cancer.
    Wieczorek E; Reszka E; Gromadzinska J; Wasowicz W
    Neoplasma; 2012; 59(3):237-47. PubMed ID: 22296495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer.
    Yi YC; Chen MK; Chen LY; Ho ES; Ying TH; Wang PH; Yang SF
    Clin Chim Acta; 2009 Nov; 409(1-2):127-31. PubMed ID: 19758569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TaqMan method for SNP genotyping.
    Shen GQ; Abdullah KG; Wang QK
    Methods Mol Biol; 2009; 578():293-306. PubMed ID: 19768602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group additive regression models for genomic data analysis.
    Luan Y; Li H
    Biostatistics; 2008 Jan; 9(1):100-13. PubMed ID: 17513311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphism genotyping in MMP genes: the 5' nuclease assay.
    Laxton R; Ye S
    Methods Mol Biol; 2010; 622():221-9. PubMed ID: 20135285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?
    Memtsas V; Zarros A; Theocharis S
    Expert Opin Ther Targets; 2009 Sep; 13(9):1105-20. PubMed ID: 19604124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between familial risks of cancer and the effects of heritable genes and their SNP variants.
    Hemminki K; Bermejo JL
    Mutat Res; 2005 Dec; 592(1-2):6-17. PubMed ID: 15990124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.
    Anderson JE; Hansen LL; Mooren FC; Post M; Hug H; Zuse A; Los M
    Drug Resist Updat; 2006; 9(4-5):198-210. PubMed ID: 17011811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput methods for SNP genotyping.
    Ding C; Jin S
    Methods Mol Biol; 2009; 578():245-54. PubMed ID: 19768599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for deleterious nonsynonymous single-nucleotide polymorphisms in genes involved in steroid hormone metabolism and response.
    Johnson MM; Houck J; Chen C
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1326-9. PubMed ID: 15894696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity and clinical implications of the matrix metalloproteinases.
    Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
    Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of single nucleotide polymorphisms (SNPs) for the detection of genes involved in the control of complex diseases].
    Gefel D; Maslovsky I; Hillel J
    Harefuah; 2008 May; 147(5):449-54, 476. PubMed ID: 18770970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of computational tools to predict functional SNPs effects in human ErbB genes.
    Choura M; Rebaï A
    J Recept Signal Transduct Res; 2009; 29(5):286-91. PubMed ID: 19728770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.
    Beeghly-Fadiel A; Xiang YB; Deming SL; Long JR; Xu WH; Cai Q; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1925-8. PubMed ID: 19435861
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.
    Wang Y; Ye Y; Lin J; Meyer L; Wu X; Lu K; Liang D
    Mol Carcinog; 2015 Jun; 54(6):430-9. PubMed ID: 25867973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels.
    Cheng YC; Kao WH; Mitchell BD; O'Connell JR; Shen H; McArdle PF; Gibson Q; Ryan KA; Shuldiner AR; Pollin TI
    Circ Cardiovasc Genet; 2009 Aug; 2(4):329-37. PubMed ID: 20031604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structure and function of matrix metalloproteinases].
    Olszyński K; Zimowska M
    Postepy Biochem; 2009; 55(1):76-84. PubMed ID: 19514468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.